Trial NCT01198535

View at ClinicalTrials.gov 
Aliases: NCT01207882
Org. Study IDs: NCI-2012-02905
Secondary IDs: 8511 N01CM00100 NCI-2012-02905 P30CA068485 VICC GI 09106

Last trial update was posted on 2015-05-18

MeSH Interventions

2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide Antibodies Antibodies, Monoclonal Antineoplastic Agents, Immunological Cetuximab Gamma Secretase Inhibitors and Modulators Immunoglobulins

MeSH Conditions

Adenocarcinoma Adenocarcinoma, Mucinous Carcinoma Carcinoma, Signet Ring Cell Colonic Neoplasms Cystadenocarcinoma Rectal Neoplasms Recurrence

Other Conditions

Colon Mucinous Adenocarcinoma Colon Signet Ring Cell Adenocarcinoma Rectal Mucinous Adenocarcinoma Rectal Signet Ring Cell Adenocarcinoma Recurrent Colon Carcinoma Recurrent Rectal Carcinoma Stage IVA Colon Cancer Stage IVA Rectal Cancer Stage IVB Colon Cancer Stage IVB Rectal Cancer

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID